Evidence map›Paper›PMID 25625430›Full record

ArticlePloS one2015

Altered CD161 bright CD8+ mucosal associated invariant T (MAIT)-like cell dynamics and increased differentiation states among juvenile type 1 diabetics.

Robert Z Harms, Kristina M Lorenzo, Kevin P Corley, Monina S Cabrera, Nora E Sarvetnick

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Review
  3. CD161Oncoimmunology · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Bacteroides ovatus-mediated CD27Cellular & molecular immunology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. MAIT cells: new guardians of the liver.Clinical & translational immunology · 2016
    Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Robert Z HarmsDepartment of Surgery-Transplant, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Kristina M LorenzoDepartment of Surgery-Transplant, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Kevin P CorleyPediatric Endocrinology, Children's Hospital & Medical Center, Omaha, Nebraska, United States of America.
Monina S CabreraPediatric Endocrinology, Children's Hospital & Medical Center, Omaha, Nebraska, United States of America.
Nora E SarvetnickDepartment of Surgery-Transplant, University of Nebraska Medical Center, Omaha, Nebraska, United States of America; Nebraska Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
University of Nebraska Medical Center · USChildren's Hospital & Medical Center · US

Funding

Cytokine receptor populations in human autoimmune diabetesU01AI102012 · NIAID · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SARVETNICK, NORA E · 2012 to 2016
$2.7M
NIAID NIH HHS 5 U01 AI102012-02NIAID NIH HHS U01 AI102012
6 · The paper itself

Abstract

Type 1A diabetes (T1D) is believed to be caused by immune-mediated destruction of β-cells, but the immunological basis for T1D remains controversial. Microbial diversity promotes the maturation and activation of certain immune subsets, including CD161 bright CD8+ mucosal associated invariant T (MAIT) cells, and alterations in gut mucosal responses have been reported in type 1 diabetics (T1Ds). We analyzed T cell populations in peripheral blood leukocytes from juvenile T1Ds and healthy controls. We found that proportion and absolute number of MAIT cells were similar between T1Ds and controls. Furthermore, while MAIT cell proportions increased with age among healthy controls, this trend was not observed among long-standing T1Ds. Additionally, the CD27- MAIT cell subset is significantly increased in T1Ds and positively correlated with HbA1c levels. However, after T1Ds are stratified by age, the younger group has significantly increased proportions of CD27- MAIT cells compared to age-matched controls, and this proportional increase appears to be independent of HbA1c levels. Finally, we analyzed function of the CD27- MAIT cells and observed that IL-17A production is increased in CD27- compared to CD27+ MAIT cells. Overall, our data reveal disparate MAIT cell dynamics between T1Ds and controls, as well as signs of increased MAIT cell activation in T1Ds. These changes may be linked to hyperglycemia and increased mucosal challenge among T1Ds.

Indexed as

AdolescentAge DistributionCase-Control StudiesCD8-Positive T-LymphocytesCell DifferentiationChildChild, PreschoolDiabetes Mellitus, Type 1FemaleGlycated HemoglobinHumansInterleukin-17Lymphocyte CountMaleNK Cell Lectin-Like Receptor Subfamily BGlycated Hemoglobinhemoglobin A1c protein, humanIL17A protein, humanInterleukin-17KLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily B

Identifiers

PMID25625430
PMCPMC4307988
OpenAlexW1985280014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.